drugset / Trial / NCT00188812
Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
one year extension study following a previous double-blind study to evaluate safety of the drug
Timeline
- Start
- 2004-05
- Primary completion
- —
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 5 mg | — |
| Subject | Donepezil | Small molecule | 10 mg | — |